Approved Study Database

Ref. No. Scientific Title Principal investigator
2016.328 Epigenetic markers of type 2 diabetes and diabetic complications Prof. MA Ronald
馬青雲
2015.316 Maternal exposure to Perfluorooctane sulfonate (PFOS) and the risk of childhood obesity and metabolic abnormalities in the offspring- analysis of a longitudinal birth cohort Prof. MA Ronald
馬青雲
2013.432 Identification of epigenetic markers in offspring exposed to maternal hyperglycaemia Prof. MA Ronald
2015.040 Progression of glucose intolerance, cardiometabolic risk factors and subclinical atherosclerosis in Chinese women with Polycystic Ovary Syndrome Prof. MA Ronald
2013.447 Developing a Metagenomic Next-Generation Sequencing Software Platform for Discovering Biomarkers with Application to Obesity and Type 2 Diabetes Prof. MA Ronald
2016.103 Unraveling the link between maternal hyperglycaemia and childhood obesity: Genome-wide methylation analysis in a prospective cohort of untreated gestational diabetes Prof. MA Ronald
馬青雲
2015.473 Identification of genetic loci for birthweight and cardiometabolic traits in childhood Prof. MA Ronald
馬青雲
2013.042 Identification of clinical and genetic predictors of hyperglycaemia and impaired beta-cell function in Chinese children- an analysis using mother-offspring pairs Prof. MA Ronald
2013.304 An integrated trans-omics approach to diabetic cardio-renal complications: from novel discoveries to personalized medicine Substudy 2: The Hong Kong Diabetes Biobank Prof. MA Ronald
2011.047 Identification of genetic variants assocaited with atrial fibrillation and its effect in subjects with diabetes Prof Ma Ronald
2013.187 An integrated trans-omics approach to diabetic cardio-renal complications: from novel discoveries to personalized medicine Prof. MA Ronald
2011.354 Identification of epigenetic markers associated with maternal diabetes and obesity Prof. MA Ronald
2011.302 Identificatin and large-scale replication of genetic predictors of diabetic kidney disease and diabetic retinopathy in the Chinese population Prof Ma Ronald
2011.118 Genetic determinants of obesity and cardiometabolic traits in Chinese adolescents Prof. Ma Ronald
2008.518 Progression of cardio-metabolic risk factors in Chinese women with Polycystic Ovary Syndrome Prof Ma Ronald
2013.251 An integrated trans-omics approach to diabetic cardio-renal complications: from novel discoveries to personalized medicine - Substudy 1: Transcriptome analysis of diabetic kidney disease Prof. MA Ronald
2008.519 The role of neurohormonal dysregulation in the transgenerational effects of maternal diabetes Prof Ma Ronald
2018.357 Comprehensive evaluation and mechanism investigation of the PAX4 gene R192H variant on diabetes, diabetes-related traits and diabetic complications Prof. MA Ronald
馬青雲
2025.200 Using data to transform diabetes care and patient lives: Substudy 1: Hong Kong Gestational Diabetes Register Prof. MA Ronald
2022.475 Translating multi-omic discoveries to transform diabetes care and reduce diabetic complications Substudy 1: A randomized controlled trial to evaluate the clinical utility of communicating polygenic risk scores in diabetes Prof. MA Ronald
2023.118 Identifying genetic determinants of drug response in Chinese patients with type 2 diabetes for precision therapeutics Prof. MA Ronald Ching Wan
馬青雲
2022.207 The impact of early-life exposure to metabolic abnormalities on pubertal development - from epidemiological analyses to mechanisms Prof. MA Ronald Ching Wan
馬青雲
2021.559 The use of NT-proBNP for stratifying risk of cardio-renal complications in Chinese patients with Type 2 diabetes Prof. MA Ronald Ching Wan
馬青雲
2021.444 Improving pregnancy outcomes, mothers’ and children’s metabolic health through dietary intervention and lifestyle modification during pregnancy Prof. MA Ronald Ching Wan
馬青雲
2022.141 Using data to transform diabetes care and patient lives Prof. MA Ronald Ching Wan
馬青雲
2021.441 A non-blinded retrospective biomarker add-on study to FIGARO-DKD for Bioprofiling the pharMacodynamic response to finerenone in FIGARO-DKD subjects (FIGARO-BM) Dr. MA Ronald Ching Wan
馬青雲
2023.146 Improving Diabetes Care for young patients Prof. MA Ronald Ching Wan
馬青雲
2018.458 Translating multi-omic discoveries to transform diabetes care and reduce diabetic complications Prof. MA Ronald Ching Wan
馬青雲
2018.476 The Fenofibrate And Microvascular Events in Type 1 diabetes Eye. A randomised trial to evaluate the efficacy on retinopathy and safety of fenofibrate in adults with type 1 diabetes; A multicentre double-blind placebo-controlled study in Australia and Internationally Dr. MA Ronald Ching Wan
馬青雲
2019.315 A multicenter, multinational, prospective, interventional, single-arm, Phase IV study evaluating the clinical efficacy and safety of 26 weeks of treatment with insulin glargine 300 U/mL (Gla-300) in patients with Type 2 diabetes mellitus uncontrolled on basal insulin Prof. MA Ronald Ching Wan
馬青雲教授
2020.120 Type 2 Diabetes Organopathy by Magnetic Resonance Imaging (T2DOM) Prof. MA Ronald Ching Wan
馬青雲
2019.152 Archival Of Human Biological Samples Of Investigator-initiated Studies In CU-Med Biobank Prof. MA Ronald Ching Wan
2019.232 Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes (SOUL) Prof. MA Ronald Ching Wan
馬青雲
2020.287 Effect and safety of semaglutide 2.4 mg once-weekly on weight management in subjects with overweight or obesity Dr. MA Ronald Ching Wan
馬青雲
2019.138 Establishing the basis for Precision Medicine for Hyperglycaemia in Pregnancy-the Stratification of Hyperglycaemia in Pregnancy (SHIP) Study Prof. MA Ronald Ching Wan
馬青雲
2015.547 A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease in addition to standard of care Prof. MA Ronald Ching Wan
馬青雲
2016.442 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE, THE VERTIS CV STUDY Prof. MA Ronald Ching Wan
馬青雲
2014.645 The effect of maternal vitamin D at pregnancy on adverse pregnancy outcome and children offspring’s cardio-metabolic risk in early childhood Prof. MA Ronald Ching Wan
2015.165 The impact of Gestational Diabetes Mellitus on mother and their children’s cardio-metabolic risks - a 22-year follow up study Prof. MA Ronald Ching Wan
2013.500 Gestational age specific thyroid function reference range in Hong Kong Prof. MA Ronald Ching Wan
2017.268 A randomized clinical trial using a postnatal lifestyle modification program to improve diet, adiposity and metabolic outcome in mothers with gestational diabetes and their offspring Prof. MA Ronald Ching Wan
2014.424 DECLARE Dapagliflozin Effect on CardiovascuLAR Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes Prof. MA Ronald Ching Wan
2015.641 The impact of gestational diabetes mellitus and vitamin D deficiency during pregnancy on children’s cardiometabolic risk and methylation Prof. MA Ronald Ching Wan
2017.291 Validation of a novel assay for measurements of biologically active Angiotensin peptides(AngP) by Liquid chromatography Mass Spectrometry(LCMS)for the screening and diagnosis of Conn’s syndrome in hypertensive patients Prof. MA Ronald Ching Wan
馬青雲
2011.407 The cardiometabolic risk amongst women with a prior history of hypertensive disorder Prof. MA Ronald Ching Wan
2012.325 Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Follow-up Study Prof. MA Ronald Ching Wan
2002.119 Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study and Ancillary Studies Prof. MA Ronald Ching Wan
2012.544 Arterial stiffness indices in mothers of Hyperglycaemia and Adverse Pregnancy outcome (HAPO) study and their children offspring – a HAPO follow-up study Prof. MA Ronald Ching Wan
2008.520 The effect of maternal hyperglycaemia during pregnancy on mother's future cardiometabolic risk - a follow up on the HAPO study Prof. MA Ronald Ching Wan
2023.608 Hong Kong Precision Medicine in Diabetes Initiative Prof. MA Ronald Ching Wan

Page 178 of 289.